Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Chris Theodossiou"'
Autor:
Lynn Harrison, Michael Boyle, Chris Theodossiou, Scott Barron, Paul Schwarzenberger, Lisa Diethelm, Anna Fariss, Raymond B. Wynn, Omar M. Salazar
Publikováno v:
American Journal of Clinical Oncology. 27:395-399
Hypofractionated chest radiotherapy has been used as an alternative when standard fractionated schedules are neither practical nor feasible. To explore docetaxel as radiosensitizer in a hypofractionated chest irradiation schedule, a docetaxel dose es
Publikováno v:
Clinical Obstetrics and Gynecology. 45:820-829
Autor:
Chandan Prasad, Everett G. Robert, Jay D. Hunt, Chris Theodossiou, David V. Schapira, Thomas W. Axelrad, Nebojsa Skrepnik
Publikováno v:
Cancer. 86:1596-1601
BACKGROUND Thyroid hormones are endocrine modulators of several vital processes that are crucial to tumor growth and differentiation. Several anecdotal reports in the literature suggest that some histologic types of carcinoma may remain in a dormant
Autor:
Jay K. Kolls, Paul Schwarzenberger, James A. Eastham, Mark A. Batzer, Robert E. Rhoads, Chris Theodossiou, Michael Patrick Collins, David Good, Jay D. Hunt, Sidney R. Grimes
Publikováno v:
Journal of Cellular Biochemistry. 74:395-405
Prostate-specific membrane antigen (PSMA) is a protein that is expressed predominantly in normal prostate epithelial cells and in most adenocarcinomas of the prostate (Cap) and in virtually all Cap metastases. In this article we describe the cloning
Autor:
Lynn Harrison, Ann Weinacker, Richard Gaumer, Aizen J. Marrogi, P Byrne, Chris Theodossiou, Jay K. Kolls, Warren R. Summer, Paul Schwarzenberger, Scott M. Freeman, Rajagopal Ramesh
Publikováno v:
Human Gene Therapy. 9:2641-2649
Malignant mesothelioma is a tumor of the pleura for which there is no satisfactory treatment. It is almost universally fatal, regardless of the stage of the tumor at the time of diagnosis. Current treatment modalities include surgery, chemotherapy, a
Autor:
Jay K. Kolls, Chris Theodossiou, Scott M. Freeman, P Byrne, Principal Investigator: Paul Schwarzenberger, Ann Weinacker, Aizen J. Marrogi, Richard Gaumer, Co-Investigators: Lynn Harrison, Rajagopal Ramesh, Study Contact: Judy Norton, Warren R. Summer
Publikováno v:
Human Gene Therapy. 9:2641-2649
Malignant mesothelioma is a tumor of the pleura for which there is no satisfactory treatment. It is almost universally fatal, regardless of the stage of the tumor at the time of diagnosis....
Autor:
Scott M. Freeman, Dinghua Lei, Ann Weinacker, Peng Ye, Jay K. Kolls, Paul Schwarzenberger, Chris Theodossiou, Warren R. Summer
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 19:333-337
Malignant mesothelioma (MM) is a thoracic malignancy that is increasing in incidence. Since it is uniformly fatal and kills by local spread, investigators have proposed that MM is a good target for novel treatment approaches, such as gene therapy. We
Autor:
Eva Perdahl-Wallace, Vesna Najfeld, Chris Theodossiou, Lewis B. Silverman, Angela Scalise, Kevin Troy
Publikováno v:
Cancer Genetics and Cytogenetics. 63:89-94
We report three patients with acute lymphoblastic leukemia with biphenotypic and early progenitor phenotype who had del(5q). In the first patient, the del(5q) was the sole abnormality; in the second patient, the del(5q) was interpreted as subclonal e
Publikováno v:
The American Journal of the Medical Sciences. 316:351-353
Two cases of plasmacytoma in the setting of human immunodeficiency virus infection are presented. The currently available literature is reviewed.
Autor:
Weitao Huang, Jay K. Kolls, Paul Schwarzenberger, Peter Oliver, Tolu Osidipe, Chris Theodossiou
Publikováno v:
The American journal of the medical sciences. 321(2)
Background Targeted, specific receptor mediated gene transfer is a major goal of gene therapy research to accomplish gene transfer exclusively to the desired cell population. Methods First, the use of natural receptor for stem cell factor and transfe